ArticleClinical and experimental medicine2025

CD2AP is a disulfidptosis modulator and prognostic biomarker in hepatocellular carcinoma.

Yingzheng Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.